1-4 of 4
Mark R. Litzow, M.D.
Close
Sort by
Journal Articles

Germinal Center B Cell and Non-Germinal Center B Cell-Like DLBCL Have Similar Clinical Features at the Time of Progression and Comparable Outcome Following Autologous HSC Transplantation.

Luciano J. Costa, MD, PhD, Andrew L. Feldman, M.D., Ivana N. Micallef, M.D., David J. Inward, M.D., Patrick B. Johnston, M.D., Ph.D., Luis F. Porrata, M.D., Mark R. Litzow, M.D., Stephen M. Ansell, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 1901.
https://doi.org/10.1182/blood.V110.11.1901.1901
Published: 2007
Journal Articles

Early Peripheral Blood Blast Clearance during Induction Chemotherapy for Acute Myeloid Leukemia (AML) Predicts Superior Relapse-Free Survival.

Michelle A. Elliott, MD, Mark R. Litzow, M.D., Louis Letendre, M.D., Robert C. Wolf, Curtis A. Hanson, M.D., Ayalew Tefferi, M.D., Martin S. Tallman, M.D.
Journal: Blood
Blood (2007) 110 (11): 1848.
https://doi.org/10.1182/blood.V110.11.1848.1848
Published: 2007
Journal Articles

Allogeneic HSC Transplantation for Multiple Myeloma: A Single Institution Experience.

Luciano J. Costa, MD, PhD, Shaji Kumar, M.D., Angela Dispenzieri, M.D., Suzanne E. Hayman, M.D., Francis K. Buadi, M.D., Mark R. Litzow, M.D., Morrie A. Gertz, M.D., Martha Q. Lacy, M.D.
Journal: Blood
Blood (2007) 110 (11): 3036.
https://doi.org/10.1182/blood.V110.11.3036.3036
Published: 2007
Journal Articles

Deletion 13 by FISH Provides Prognostic Information on Overall Survival and Time to Progression Independent of Serum Beta 2 Microglobulin and Bone Marrow Plasma Cell Labeling Index in Myeloma Patients Undergoing Stem Cell Transplantation.

Morie Abraham Gertz, M.D., Martha Q. Lacy, M.D., Angela Dispenzieri, M.D., Philip R. Greipp, M.D., Mark R. Litzow, M.D., Kim J. Henderson, BA, Scott VanWier, BA, Greg Ahmann, BA, Rafael Fonseca, M.D.
Journal: Blood
Blood (2004) 104 (11): 4852.
https://doi.org/10.1182/blood.V104.11.4852.4852
Published: 2004